Review of intra-hepatic cellular senescence and liver regeneration
This abstract describes a review of how senescent cells inside the liver affect liver repair and disease, and of proposed treatments that may target harmful senescent cells. It reports no new experiments or patient results. [1]
Automatic summary · not editorially reviewed
The key findings
The review describes intra-hepatic cellular aging as typically involving diminished proliferative capacity, genomic instability, mitochondrial dysfunction and exacerbated inflammatory responses. [1]
According to the abstract, acute transient senescence may aid tissue repair via SASP, while chronic accumulation of senescent cells suppresses regenerative capacity. [1]
The abstract names small-molecule anti-aging compounds, gene therapy and stem-cell-based approaches as interventions targeting cellular senescence that may be promising for future liver disease management. [1]
The source at a glance
- Study type / format
- Review article (abstract only)
- Population / context
- Cells and processes inside the liver (hepatocytes and their microenvironment), as discussed in a review
- Summary based on
- Study abstract
- Original publication
- September 28, 2026
Senescence features and liver disease in the review
The review describes intra-hepatic cellular aging as typically showing reduced ability to divide, genomic instability, mitochondrial dysfunction and stronger inflammatory responses. According to the abstract, these features contribute to impaired liver function and to the development of related diseases. The text presents this as background for the review, not as results of a new study.
Supporting source [1]
Short-term versus chronic senescence in liver repair
The abstract describes a paradox: acute, transient senescence may support tissue repair through the senescence-associated secretory phenotype (SASP), a set of substances senescent cells release. In contrast, chronic accumulation of senescent cells is said to disrupt the liver microenvironment and suppress regenerative capacity. Liver regeneration itself depends on hepatocyte proliferation and differentiation, regulated by signaling pathways and microenvironmental factors. The review therefore argues that treatments would need to distinguish beneficial from detrimental senescent cell populations.
Supporting source [1]
Proposed senescence-targeting strategies in the review
The abstract lists interventions targeting cellular senescence: small-molecule anti-aging compounds, gene therapy and stem-cell-based approaches. It calls these potentially promising therapeutic approaches for future liver disease management and says the review explores strategies that selectively target pathological senescence to promote liver regeneration. These are described as possible future directions, not as established or tested treatments.
Supporting source [1]
How to interpret this
This is an abstract of a review; the full text was not reviewed. It reports no study design, sample, follow-up or outcome data, and the proposed interventions are not shown to work in patients.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Yang J, Li Y, Feng Y, Chen Y, Li Z, Zhang N, Lai M, Zou W. · europepmc.org · September 28, 2026